Abbott Laboratories’ Q2 results provide ‘hope’ for medical device markets, says analyst

Devices used in elective, non-urgent procedures are thought to be some of the worst affected in the medical industry (Credit: Phase 2 Medical Manufacturing)



Related Article
Recommended Whitepaper

View More